Evidence is presented that defective interfering (DI) Semliki Forest virus (SFV) can modulate the systemic infection in mice initiated by intraperitoneal inoculation of l0 LDso SFV. Either the mean time of death was delayed or mice failed completely to develop any sign of disease. This prophylactic activity of DI virus was not due to the stimulation of an adaptive immune response since an equivalent amount of noninfectious virus antigen did not change the course of disease.
Defective interfering (DI) virus particles are produced during the replication of many, possibly all, animal viruses (Huang & Baltimore, 1977; Perrault, 1981) and characteristically have a genome which contains deletions, often of the majority, of the standard (infectious) virus genome. This deletion means that DI virus can only replicate in cells co-infected with standard virus. Such co-infection usually results in the propagation of DI virus at the expense of standard virus, hence the phenomenon of interference (Huang & Baltimore, 1977; Holland et al., 1980; Perrault, 1981) .
The possibility that DI particles could exert effects on virus infections 01 vivo was first postulated by Huang & Baltimore (1970) and it has been suggested that DI particles may modulate both acute and persistent virus infections , but there are remarkably few results to support this proposition. Claims have been made that DI viruses have the capacity to interfere in vivo using the vesicular stomatitis virus (VSV) system (Doyle & Holland, 1973 ; Holland & Villarreal, 1975 ; Rabinowitz et al., 1977) , with reovirus (Spandidos & Graham, 1976), with influenza virus (yon Magnus, 195l ; Rabinowitz & Huprikar, 1979) , and with lymphocytic choriomeningitis virus (Welsh et al., 1977) . However, none of this work included controls to monitor the possible immunogenic effects of DI virus particles which were always inoculated in large amounts. Authenticated modulation of ~nfection by DI virus has been reported only for infection by VSV and for Semliki Forest virus (SFV) (Dimmock & Kennedy, 1978; Crouch et al., 1982; Barrett & Dimmock, 1984a, b) . These were both primarily infections of the central nervous system by injection intracerebrally (VSV) or by intranasal inoculation which allows SFV to ascend the olfactory nerves into the brain. Two reports have claimed that DI viruses modulated systemic infections but neither included controls for immunogenic effects of the DI virus antigens: Spandidos & Graham (1976) prevented a lethal reovirus infection in 2-day-old rats inoculated subcutaneously while Fultz et al. (1982) showed that hamsters could be protected against a lethal VSV infection by DI virus inoculated intraperitoneally.
Mice inoculated with virulent strains of SFV by the intraperitoneal route initially undergo a local infection in muscle (Pusztai et al., 1971) which then spreads systemically before virus reaches the central nervous system (Bradish & Allner, 1972; Bradish et al., 1975) . Here we report that DI virus modulates such infections by increasing the survival ~ime or completely preventing any signs of disease. We also show that this outcome of infection depends on the ratio of DI : standard virus and that different preparations of DI virus modulate infection in different ways.
Virulent SFV (ts+; standard virus) was grown in BHK cells (m.o.i. = 0.1) as described by Dimmock & Kennedy (1978) . DI SFV preparations were all derived by serial undiluted passage Short communication Barrett et al. (1981) except that virus was placed 10 cm below a u.v. lamp (Gelman Sciences Ltd., U.K.) with a dosage of 14 ~tW/s/cm 2, After irradiation no infectivity was detectable by plaque assay. The haemagglutination assay was performed according to Clarke & Casals (1958) .
t The designation indicates that this DI virus preparation has been made by four undiluted passages (p) in BHK cells. Lower case letters indicate sister stocks.
in BHK cells and were inoculated together with a constant m.o.i, of 50 p.f.u./cell for 24 h at 37 °C. DI SFV preparations are designated by the number of undiluted passages and a letter to indicate sister stocks (e.g. pl3a). DI SFV pl3a was derived from the p8 DI SFV used by Dimmock & Kennedy (1978) . DI SFV p4 was generated independently from standard virus as described above. Interference was quantified by measuring the inhibition of incorporation of [3H]uridine by virus-specified RNA in L929 cells co-inoculated with standard SFV (Barrett et al., 1981) . Male CFLP random-bred mice 4 to 5 weeks old and weighing about 25 g bought from Hacking and Churchill Ltd (Wyton, Huntingdon, Cambridgeshire, U.K.), were used 3 to 6 days after delivery. Animals were inoculated intraperitoneally (i.p.) with a 100 ktl vol. of DI SFV containing 10 LDso standard virus (1.25 × l0 s p.f.u./LDso). Control mice were inoculated in exactly the same way with non-infectious u.v.-irradiated standard SFV replacing DI virus, as a control for possible immunogenic effects and to demonstrate that the presence of SFV antigen did not prevent infection (see below).
Details of the passage histories, haemagglutination and interference assay titres of the DI SFV preparations used in the experiments are shown in Table 1 . In addition to DI virus, these preparations also contained between 107 and 108 p.f.u./ml standard virus. Since for CFLP mice inoculated by the i.p. route there are about l0 s p.f.u./LDso it was necessary to remove the excess infectivity. With current techniques it is not possible to separate alphavirus DI and standard virus physically, but u.v. irradiation selectively inactivates the standard virus genome (tool. wt. 4.2 × 106), leaving the biological activity of the DI virus genome (mot. wt. < 1 x 10 6) relatively unaffected (Barrett et al., 1981) . The length of exposure was chosen to ensure that irradiated DI virus preparations contained no infectivity detectable by plaque assay or by inoculation into mice by the intranasal route.
In order to analyse the modulation of SFV infection in mice by DI SFV it was necessary to distinguish between the intrinsic interfering properties of the DI virus and its effect as an immunogen. The total amount of SFV antigen in DI virus preparations was determined by haemagglutination (HA) and non-infectious SFV antigen, prepared by u.v.-irradiating standard SFV, was diluted to the same HA titre (4 HAU/ml), and used as a control for the immunogenic effects of DI virus. U.v. SFV antigen did not alter the course of disease caused by 10 LDso standard virus and did not reduce its lethality (data not shown).
SFV causes an encephalitis in mice after i.p. inoculation and the disease induced in adult CFLP mice inoculated with 10 LDs0 followed a reproducible pattern. Mice remained apparently healthy until 5 days post-infection and then showed signs of malaise (ruffled fur and inactivity) which was followed within 24 h by paralysis of the hind limbs. This progressed to complete paralysis and death normally by day 8. With 10 LDso, 80 to 90% of mice contract a lethal infection and the remainder appear to have a silent infection which is nonetheless immunizing.
Mice were inoculated with 100 lal of a mixture of 10 LDso standard virus plus DI virus and controls received 10 LDs0 plus non-infectious u.v.-irradiated standard virus (u.v. SFV; 4 HAU/ml) as described above (Table 2) . DI SFV modulated the course of disease by retarding * In this experiment, groups of nine mice were infected. Control mice inoculated with u.v. SFV, DI SFV or inoculated with diluent remained healthy throughout the duration of the experiment (20 days).
t The percentage of mice that survived through inoculation of DI virus was corrected by subtraction of the percentage surviving 10 LDs0 + u.v. SFV only.
:~ U.v. SFV is non-infectious u.v.-irradiated standard virus at a concentration of 4 HAU/ml, § DI SFV pl3a, u.v,-irradiated for 60 s, 4 HAU/ml. the onset of clinical signs of malaise (data not shown) and the progression through paralysis to death. For example, at 6-75 days post-infection 67~o of the mice infected with 10 LDso + u.v. SFV were dead compared with 11~o of those inoculated with t0 LDso + DI SFV. The mean time of death for 10 LDs0 + u.v. SFV was 6.6 days and this was extended to 9-2 days for 10 LDso + DI SFV. Overall, inoculation of mice with 10 LDso + DI SFV resulted in more than double the number of survivors compared with inoculation of 10 LDso + u.v. SFV. Control mice inoculated with only u.v. SFV or only DI SFV remained healthy. We have reported elsewhere that DI SFV preparations are biologically heterogeneous and vary in their ability to protect mice by the intranasal route to the extent that some protect efficiently whereas others, of the same interference titre in vitro, do not protect at all (Barrett & Dimmock, 1984 b) . The ability of DI viruses p4 and p 13a to protect mice after i.p, inoculation is shown in Table 3 . These preparations contain identical amounts of SFV antigen and have similar interference titres (Table 1) . Both p4 and pl 3a modulated the disease to the same extent and similar numbers survived infection (27 and 26~ respectively) without showing signs of disease. However, they differed in the extent to which they delayed death. Mice treated with DI SFV pl3a died on average 34 h later than animals inoculated with 10 LDso + u.v. SFV, while DI SFV p4 had no effect on the mean time of death. Thus, delay of death and the complete absence of disease may represent separate manifestations of the interactions of DI viruses and SFV-infected mice. Since the two DI SFV preparations have the same antigenic mass and similar interference titres, we conclude that the differences in modulation are due to intrinsic qualitative differences.
The effects of DI virus p4 and pl3a vary according to the route of inoculation. When mice were inoculated and treated with DI SFV by the intranasal route the majority had a subclinical infection and in the remainder the disease followed its usual pattern without any delay in onset (Barrett & Dimmock, 1984b ). Other DI virus preparations which modulated infection when inoculated by the i.p. route were inactive by the intranasal route, e.g. DI SFV p6 protected 47~ of mice inoculated i.p. but none when inoculated by the intranasal route (unpublished data). Earlier experiments suggested that modulation by DI virus could be made more effective by increasing the ratio of DI :standard virus inoculated (Dimmock & Kennedy, 1978; Barrett & Dimmock, 1984a ) but large increases in the amount of DI virus make it demonstrably immunogenic. However, the lethality of standard virus can be potentiated by pretreating mice 
